| scholarly article | Q13442814 |
| P50 | author | Varda Rotter | Q16131089 |
| P2093 | author name string | Hilla Solomon | |
| Adit Ben-Baruch | |||
| Tsipi Meshel | |||
| Tal Leibovich-Rivkin | |||
| Yosef Buganim | |||
| P2860 | cites work | Hallmarks of Cancer: The Next Generation | Q22252312 |
| Creation of human tumour cells with defined genetic elements | Q28141602 | ||
| Putting tumours in context | Q28207789 | ||
| Microenvironmental regulation of metastasis | Q29547660 | ||
| Function and activation of NF-kappa B in the immune system | Q29547790 | ||
| Ras oncogenes: split personalities | Q29615405 | ||
| Hyperactive Ras in developmental disorders and cancer | Q29616397 | ||
| CXC chemokines in cancer angiogenesis and metastases | Q30432791 | ||
| Chemokines as mediators of neovascularization | Q30438032 | ||
| Tumor necrosis factor-mediated interactions between inflammatory response and tumor vascular bed. | Q33325343 | ||
| Stimulus-specific regulation of chemokine expression involves differential activation of the redox-responsive transcription factors AP-1 and NF-kappaB. | Q33542042 | ||
| Transient depletion of p53 followed by transduction of c-Myc and K-Ras converts ovarian stem-like cells into tumor-initiating cells. | Q53226951 | ||
| p53 Regulates the Ras circuit to inhibit the expression of a cancer-related gene signature by various molecular pathways. | Q53301403 | ||
| Prolonged culture of telomerase-immortalized human fibroblasts leads to a premalignant phenotype. | Q53373925 | ||
| Tumor suppressor p16INK4a determines sensitivity of human cells to transformation by cooperating cellular oncogenes | Q53374378 | ||
| Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation. | Q53548575 | ||
| Chemokines and Cancer: A Fatal Attraction | Q56942343 | ||
| Three birds with one stone | Q59053988 | ||
| Tumour necrosis factor and cancer | Q61819217 | ||
| A clinical study assessing the tolerability and biological effects of infliximab, a TNF-α inhibitor, in patients with advanced cancer | Q61819218 | ||
| Tumor Necrosis Factor α As a New Target for Renal Cell Carcinoma: Two Sequential Phase II Trials of Infliximab at Standard and High Dose | Q61819220 | ||
| Interleukin-1-dependent sequential chemokine expression and inflammatory cell infiltration in ischemia-reperfusion injury | Q62735783 | ||
| Cytokine induction of monocyte chemoattractant protein-1 gene expression in human endothelial cells depends on the cooperative action of NF-kappa B and AP-1 | Q73396203 | ||
| Species- and cell type-specific requirements for cellular transformation | Q80482709 | ||
| Transcriptional programs following genetic alterations in p53, INK4A, and H-Ras genes along defined stages of malignant transformation | Q81805862 | ||
| MCP-1: chemoattractant with a role beyond immunity: a review | Q33633544 | ||
| TP53 mutations in human cancers: origins, consequences, and clinical use | Q33685392 | ||
| Mutant p53 gain-of-function in cancer | Q33687048 | ||
| Why not treat human cancer with interleukin-1 blockade? | Q33833871 | ||
| Tumor necrosis factor: a master-regulator of leukocyte movement | Q33846423 | ||
| The interleukin-8 pathway in cancer. | Q34871322 | ||
| Inflammatory mediators in breast cancer: coordinated expression of TNFα & IL-1β with CCL2 & CCL5 and effects on epithelial-to-mesenchymal transition | Q34984217 | ||
| Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells | Q35698582 | ||
| CCL2 (monocyte chemoattractant protein-1) and cancer | Q35832328 | ||
| Tumor necrosis factor, cancer and anticancer therapy. | Q36055874 | ||
| Involvement of chemokine receptors in organ-specific metastasis | Q36455122 | ||
| TNF-alpha in promotion and progression of cancer | Q36585132 | ||
| Tuning inflammation and immunity by chemokine sequestration: decoys and more | Q36662451 | ||
| The chemokine and chemokine receptor superfamilies and their molecular evolution | Q36698659 | ||
| Inhibitors of chronically active ras: potential for treatment of human malignancies. | Q37090382 | ||
| Is interleukin-1 a good or bad 'guy' in tumor immunobiology and immunotherapy? | Q37118170 | ||
| The inflammatory chemokines CCL2 and CCL5 in breast cancer | Q37148637 | ||
| New insights on the role of CXCR4 in cancer metastasis | Q37181856 | ||
| The chemokine receptors CXCR4 and CXCR3 in cancer | Q37393013 | ||
| The good and the bad of chemokines/chemokine receptors in melanoma | Q37394981 | ||
| Requirement for NF-kappaB signalling in a mouse model of lung adenocarcinoma | Q37428076 | ||
| When mutants gain new powers: news from the mutant p53 field. | Q37582777 | ||
| Signal transduction pathways linking the activation of alveolar macrophages with the recruitment of neutrophils to lungs in chronic obstructive pulmonary disease | Q37618178 | ||
| Chemokines and chemokine receptors: new insights into cancer-related inflammation. | Q37694068 | ||
| Inactivation of the p53 tumor suppressor gene and activation of the Ras oncogene: cooperative events in tumorigenesis. | Q37761951 | ||
| Understanding wild-type and mutant p53 activities in human cancer: new landmarks on the way to targeted therapies | Q37802195 | ||
| Transcriptional regulation of the human monocyte chemoattractant protein-1 gene. Cooperation of two NF-kappaB sites and NF-kappaB/Rel subunit specificity. | Q38340932 | ||
| Chemokine receptor CXCR4-mediated transformation of mammary epithelial cells by enhancing multiple RTKs expression and deregulation of the p53/MDM2 axis | Q39550973 | ||
| Tumor suppressor p53 restricts Ras stimulation of RhoA and cancer cell motility | Q40169273 | ||
| Analysis of tumor-host interactions by gene expression profiling of lung adenocarcinoma xenografts identifies genes involved in tumor formation | Q40441318 | ||
| Transcription factors as activators of gene transcription: AP-1 and NF-kappa B. | Q41514906 | ||
| A phase II study of etanercept (Enbrel), a tumor necrosis factor alpha inhibitor in patients with metastatic breast cancer. | Q42637870 | ||
| Differential tumorigenicity of 3T3 cells transformed in vitro with polyoma virus and in vivo selection for high tumorigenicity | Q42798727 | ||
| Enhanced metastatic potential of tumor cells harvested from spontaneous metastases of heterogeneous murine tumors. | Q42798966 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P304 | page(s) | 55-76 | |
| P577 | publication date | 2012-01-20 | |
| P1433 | published in | Cancers | Q27722963 |
| P1476 | title | Tumor-promoting circuits that regulate a cancer-related chemokine cluster: dominance of inflammatory mediators over oncogenic alterations | |
| P478 | volume | 4 |
Search more.